Ledger.Open graph →
SEC Form D · filed March 7, 2018

Koligo Therapeutics Inc

Offering
$2.0M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Louisville, KY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

David Platt · Newton, MAExec · DirectorDana E. Schmidt · San Francisco, CAExec · DirectorBrian R. Gaister · BETHESDA, MDExec · DirectorUmesh Padval · Fremont, CAExec · DirectorStuart B. Williams · Louisville, KYExec · DirectorAnders N. Utter · Newton, MAExec · DirectorNobi Kambe · Fremont, CAExec · DirectorDavid B. Blanford · Louisville, KYExec · DirectorBalamurugan B. Appakalai · Louisville, KYExec · DirectorLeslie E. Ross · New York, NYExec · DirectorMatthew B. Lehman · Louisville, KYExec · DirectorJennifer K. Ciresi · San Francisco, CAExec · DirectorMichael B. Hughes · Louisville, KYExec · DirectorMichel A. Del Buono · San Francisco, CAExec · DirectorJames Donnelly · Austin, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗